Home
Company
Our Vision
Our Leadership Team
Naronapride (ATI-7505)
About Naronapride (ATI-7505)
Mechanism of Action
Development Status
Chemistry and Manufacturing
Latest Regulatory Developments
Knowledge Center
Chronic Idiopathic Constipation
Irritable Bowel Syndrome
GERD
Functional Dyspepsia
Gastroparesis
Other Therapeutic Indications
News
Press
>
Sinovant Sciences and Renexxion Form Partnership to Develop Naronapride in China BEIJING, SHANGHAI, and Menlo Park
Renexxion Achieves Positive FDA Guidance for Phase 3 ready GI Drug Naronapride
Contact
Press
July 17, 2018
Sinovant Sciences and Renexxion Form Partnership to Develop Naronapride in China
Download.pdf
Nov. 17, 2016
Bioworld: Renexxion advances former Aryx GI drug under new FDA guidance
Nov. 16, 2016
Renexxion Achieves Positive FDA Guidance for Phase 3 ready GI Drug Naronapride
Download .pdf
Home
Company
Our Vision
Our Leadership Team
Naronapride (ATI-7505)
About Naronapride (ATI-7505)
Mechanism of Action
Development Status
Chemistry and Manufacturing
Latest Regulatory Developments
Knowledge Center
Chronic Idiopathic Constipation
Irritable Bowel Syndrome
GERD
Functional Dyspepsia
Gastroparesis
Other Therapeutic Indications
News
Press
>
Sinovant Sciences and Renexxion Form Partnership to Develop Naronapride in China BEIJING, SHANGHAI, and Menlo Park
Renexxion Achieves Positive FDA Guidance for Phase 3 ready GI Drug Naronapride
Contact